LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

被引：7

作者：

Westendorf, Kathryn ^{[1
]}

Zentelis, Stefanie ^{[1
]}

Wang, Lingshu ^{[2
]}

Foster, Denisa ^{[3
]}

Vaillancourt, Peter ^{[3
]}

Wiggin, Matthew ^{[1
]}

Lovett, Erica ^{[1
]}

van der Lee, Robin ^{[1
]}

Hendle, Joerg ^{[3
]}

Pustilnik, Anna ^{[3
]}

Sauder, J. Michael ^{[3
]}

Kraft, Lucas ^{[1
]}

Hwang, Yuri ^{[1
]}

Siegel, Robert W. ^{[4
]}

Chen, Jinbiao ^{[4
]}

Heinz, Beverly A. ^{[4
]}

Higgs, Richard E. ^{[4
]}

Kallewaard, Nicole L. ^{[4
]}

Jepson, Kevin ^{[1
]}

Goya, Rodrigo ^{[1
]}

Smith, Maia A. ^{[1
]}

Collins, David W. ^{[1
]}

Pellacani, Davide ^{[1
]}

Xiang, Ping ^{[1
]}

de Puyraimond, Valentine ^{[1
]}

Ricicova, Marketa ^{[1
]}

Devorkin, Lindsay ^{[1
]}

Pritchard, Caitlin ^{[1
]}

O'Neill, Aoise ^{[1
]}

Dalal, Kush ^{[1
]}

Panwar, Pankaj ^{[1
]}

Dhupar, Harveer ^{[1
]}

Garces, Fabian A. ^{[1
]}

Cohen, Courtney A. ^{[5
]}

Dye, John M. ^{[5
]}

Huie, Kathleen E. ^{[5
]}

V. Badger, Catherine ^{[5
]}

Kobasa, Darwyn ^{[6
,7
]}

Audet, Jonathan ^{[6
,7
]}

Freitas, Joshua J. ^{[3
]}

Hassanali, Saleema ^{[3
]}

Hughes, Ina ^{[3
]}

Munoz, Luis ^{[3
]}

Palma, Holly C. ^{[3
]}

Ramamurthy, Bharathi ^{[3
]}

Cross, Robert W. ^{[7
,8
,9
]}

Geisbert, Thomas W. ^{[7
,8
,9
]}

Menachery, Vineet ^{[8
,9
]}

Lokugamage, Kumari ^{[8
,9
]}

Borisevich, Viktoriya ^{[8
]}

机构：

[1] AbCellera Biol Inc, Vancouver, BC V5Y 0A1, Canada

[2] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[3] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] US Army Med Res Inst Infect Dis USAMRIID, Frederick, MD 21702 USA

[6] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3L5, Canada

[7] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada

[8] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA

[9] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA

来源：

CELL REPORTS | 2022年 / 39卷 / 07期

基金：

欧盟地平线“2020”;

关键词：

VALIDATION; IMMUNITY;

D O I：

10.1016/j.celrep.2022.110812

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibodies (mAbs) can reduce the risk of hospitalization from coronavirus disease 2019 (COVID-19) when administered early. However, SARS-CoV-2 variants of concern (VOCs) have negatively affected therapeutic use of some authorized mAbs. Using a high-throughput B cell screening pipeline, we isolated LY-CoV1404 (bebtelovimab), a highly potent SARS-CoV-2 spike glycoprotein receptor binding domain (RBD)-specific antibody. LYCoV1404 potently neutralizes authentic SARS-CoV-2, B.1.1.7, B.1.351, and B.1.617.2. In pseudovirus neutralization studies, LY-CoV1404 potently neutralizes variants, including B.1.1.7, B.1.351, B.1.617.2, B.1.427/ B.1.429, P.1, B.1.526, B.1.1.529, and the BA.2 subvariant. Structural analysis reveals that the contact residues of the LY-CoV1404 epitope are highly conserved, except for N439 and N501. The binding and neutralizing activity of LY-CoV1404 is unaffected by the most common mutations at these positions (N439K and N501Y). The broad and potent neutralization activity and the relatively conserved epitope suggest that LY-CoV1404 has the potential to be an effective therapeutic agent to treat all known variants.

引用

页数：26

共 50 条

[21] SARS-CoV-2 Variants in Pregnancy
Asirwatham, Alison
Hillman, Michelle
Khan, Lyba
Sangermano, Lisa M.
Leung, Katherine
Leftwich, Heidi K.
OBSTETRICS AND GYNECOLOGY, 2024, 143 (5S): : 5S - 6S
[22] The SARS-CoV-2 variants of concern
Passi, Gouri Rao
INDIAN PEDIATRICS, 2021, 58 (05) : 498 - 498
[23] The Sars-CoV-2 and its variants
Monetti, Marcello
Pozzetto, Bruno
Plotton, Catherine
Gocko, Xavier
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (171): : 118 - 127
[24] Understanding variants of SARS-CoV-2
Burki, Talha
LANCET, 2021, 397 (10273): : 462 - 462
[25] SARS-CoV-2 Variants of Concern
Choi, Jun Yong
Smith, Davey M.
YONSEI MEDICAL JOURNAL, 2021, 62 (11) : 961 - 968
[26] Hybrid SARS-CoV-2 variants
Rahimi, Farid
Abadi, Amin Talebi Bezmin
INTERNATIONAL JOURNAL OF SURGERY, 2022, 102
[27] Structure guided design of biparatopic nanobodies that potently neutralize SARS-CoV-2 and variants
Dhobi, Javeed
Jiang, Jiansheng
Boyd, Lisa F.
Bernard, Lafont
Zeher, Allison
Huang, Rick
Xia, Di
Natarajan, Kannan
Margulies, David H.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2022, 78 : A194 - A194
[28] Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
Raoul De Gasparo
Mattia Pedotti
Luca Simonelli
Petr Nickl
Frauke Muecksch
Irene Cassaniti
Elena Percivalle
Julio C. C. Lorenzi
Federica Mazzola
Davide Magrì
Tereza Michalcikova
Jan Haviernik
Vaclav Honig
Blanka Mrazkova
Natalie Polakova
Andrea Fortova
Jolana Tureckova
Veronika Iatsiuk
Salvatore Di Girolamo
Martin Palus
Dagmar Zudova
Petr Bednar
Ivana Bukova
Filippo Bianchini
Dora Mehn
Radim Nencka
Petra Strakova
Oto Pavlis
Jan Rozman
Sabrina Gioria
Josè Camilla Sammartino
Federica Giardina
Stefano Gaiarsa
Qiang Pan-Hammarström
Christopher O. Barnes
Pamela J. Bjorkman
Luigi Calzolai
Antonio Piralla
Fausto Baldanti
Michel C. Nussenzweig
Paul D. Bieniasz
Theodora Hatziioannou
Jan Prochazka
Radislav Sedlacek
Davide F. Robbiani
Daniel Ruzek
Luca Varani
Nature, 2021, 597 : E2 - E2
[29] An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
Xiaojing Chi
Xinhui Zhang
Shengnan Pan
Yanying Yu
Yujin Shi
Tianli Lin
Huarui Duan
Xiuying Liu
Wenfang Chen
Xuehua Yang
Lan Chen
Xiaoqian Dong
Lili Ren
Qiang Ding
Jianwei Wang
Wei Yang
Signal Transduction and Targeted Therapy, 7
[30] Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants
Kim, Ji Woong
Heo, Kyun
Kim, Hyun Jung
Yoo, Youngki
Cho, Hyun-Soo
Jang, Hui Jeong
Ko, In Young
Lee, Ho-Young
Woo, Ju Rang
Cho, Yea Bin
Lee, Ji Hyun
Yang, Ha Rim
Shin, Ha Gyeong
Choi, Hye Lim
Hwang, Kyusang
Kim, Sokho
Kim, Hanseong
Chun, Kwangrok
Lee, Sukmook
ANTIVIRAL RESEARCH, 2023, 212

← 1 2 3 4 5 →